A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Mikhail Binnewies et al.|Nature Medicine|2018Cited by 1k
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancerGorjan Hrustanovic, Trever G. Bivona, Victor Olivas et al.|Nature Medicine|2015Cited by 277